Synapse - Works

Results (352)

Clinical assessment of chronic lymphocytic leukemia samples for somatic hypermutation status by next-generation sequencing and Sanger sequencing

Meeting Abstract

Arcila, M.; Huang, Y.; Hutt, K.; Panganiban, J.; Baldi, T.; Nafa, K.; Thornes, J.; Miller, J. E.; Klass, M.
Haematologica (2015)

Fulltext@MSK | Save

Improved survival in patients ≥60 with first relapsed/refractory acute myeloid leukemia treated with vosaroxin plus cytarabine vs placebo plus cytarabine: Results from the phase 3 valor study

Meeting Abstract

Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Erba, H. P.; more...
Haematologica (2015)

Fulltext@MSK | Save

Allogeneic transplant in patients ≥60 years of age with first relapsed or refractory acute myeloid leukemia after treatment with vosaroxin or placebo plus cytarabine: Results from VALOR

Meeting Abstract

Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Erba, H. P.; Pigneux, A.; Horst, H. A.; more...
Haematologica (2015)

Fulltext@MSK | Save

Retreatment with blinatumomab after CD19-positive relapse: Experience from 3 trials in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (R/R ALL)

Meeting Abstract

Topp, M. S.; Stelljes, M.; Zugmaier, G.; Barnette, P.; Heffner, L. T.; Trippett, T.; Bargou, R.; Jia, C.; Benjamin, J.; Litzow, M. R.
Haematologica (2015)

Fulltext@MSK | Save

Efficacy and safety of CD19-targeted 19-28z CAR modified T cells in adult patients with relapsed or refractory B-ALL

Meeting Abstract

Park, J.; Riviere, I.; Wang, X.; Bernal, Y.; Purdon, T.; Halton, E.; Curran, K.; Sauter, C.; Sadelain, M.; Brentjens, R.
Haematologica (2015)

Fulltext@MSK | Save

Long-term outcome of 490 patients with early-stage extra-nodal marginal zone lymphoma

Meeting Abstract

Yahalom, J.; Teckie, S.; Qi, S.; Hsu, M.; Lovie, S.; Chelius, M.; Noy, A.; Portlock, C.
Haematologica (2015)

Fulltext@MSK | Save

NEOD001 demonstrates cardiac and renal biomarker responses in a phase 1/2 study in patients with AL amyloidosis and persistent organ dysfunction

Meeting Abstract

Liedtke, M.; Landau, H.; Comenzo, R.; Seldin, D.; Weiss, B.; ZonDer, J.; Walling, J.; Kinney, G.; Koller, M.; Gertz, M. A.
Haematologica (2015)

Fulltext@MSK | Save

Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years

Journal Article

Engelhardt, M.; Ihorst, G.; Landgren, O.; Pantic, M.; Reinhardt, H.; Waldschmidt, J.; May, A. M.; Schumacher, M.; Kleber, M.; Wäsch, R.
Haematologica (2015)

Fulltext@MSK | Save

Precision medicine in diffuse large B-cell lymphoma: Hitting the target

Journal Article

Vermaat, J. S.; Pals, S. T.; Younes, A.; Dreyling, M.; Federico, M.; Aurer, I.; Radford, J.; Kersten, M. J.
Haematologica (2015)

Fulltext@MSK | Save

MLL partial tandem duplication leukemia cells are sensitive to small molecule DOT1L inhibition

Journal Article

Kühn, M. W. M.; Hadler, M. J.; Daigle, S. R.; Koche, R. P.; Krivtsov, A. V.; Olhava, E. J.; Caligiuri, M. A.; Huang, G.; Bradner, J. E.; Pollock, R. M.; more...
Haematologica (2015)

Fulltext@MSK | Save